Clinical trials recruiting for Metabolic Syndrome (MetS)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Obicetrapib 10 mg | 1 |
| obicetrapib 10 mg + ezetimibe 10 mg FDC daily | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Kentucky | 1 |
| Maryland | 1 |
| Missouri | 1 |
| Montana | 1 |
| New Jersey | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
- Duodenal-jejunal Bypass Sleeve (DJBS) for Obesity and Metabolic Syndrome
- Norwegian Mental Illness Heart Health Study
- Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Related conditions
Trials recruiting for Metabolic Syndrome (MetS) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metabolic Syndrome (MetS) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.